VVP
RNLX

Venture Visionary Partners’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Venture Visionary Partners’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-135
Closed -$330 – 1611
2022
Q2 		$330 Buy
+135
New +$642 ﹤0.01% 1671

Other funds holding RNLX

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Venture Visionary Partners's RNLX Position: Q3 2022 in Review

Venture Visionary Partners sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2022, closing a stake of 135 shares — an estimated $330 sold.

Venture Visionary Partners first reported a position in RNLX in Q2 2022 and held it in 1 quarter. The position peaked at $330 in Q2 2022. 27 funds tracked by Wall St. Rank hold RNLX as of Q3 2022.

  • Venture Visionary Partners reported no remaining Renalytix plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 135 Renalytix plc American Depositary Shares shares in Q3 2022, an estimated $330.
  • Venture Visionary Partners first reported a position in Renalytix plc American Depositary Shares in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Renalytix plc American Depositary Shares position peaked at $330 in Q2 2022.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.